<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109255">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01878864</url>
  </required_header>
  <id_info>
    <org_study_id>OC004PDS</org_study_id>
    <secondary_id>2012-003430-16</secondary_id>
    <nct_id>NCT01878864</nct_id>
  </id_info>
  <brief_title>Effect of Local Anesthesia in Patients With Marginal Periodontitis Undergoing Scaling and Root Planning</brief_title>
  <official_title>Effect of Local Anesthesia in Patients With Marginal Periodontitis Undergoing Scaling and Root Planning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ove Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised cross-over study comparing two methods of local anaesthesia for patients
      diagnosed with periodontitis undergoing scaling and root planning. 40 patients will be
      included in the study, which aims to demonstrate that the effect of a bupivacaine lozenge is
      non-inferior to lidocaine-adrenalin injections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 periodontitis patients undergoing scaling and root planning (SRP) will be randomised to
      receive local anaesthesia by either a bupivacaine lozenge or lidocaine-adrenalin injection
      at their first visit. At the following visit, the patients will receive the opposite
      treatment.

      At each visit the patient will evaluate pain before, during and after SRP by:

        -  Visual Analog Scale (VAS) 0-10 where 0 = no pain, 10 = extreme pain.

        -  McGills Pain Questionnaire (MPQ), which gives a qualitative pain profile.

      At each visit the patient will evaluate discomfort before, during and after the SRP by:

      - Visual Analog Scale (VAS) 0-10 where 0 = no discomfort, 10 = extreme discomfort.

      Additionally the patient assesses the comfort of administration of the two local anaesthesia
      as well as the taste of the bupivacaine lozenge. The investigator also evaluates the scaling
      procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>To demonstrate a non-inferior effect on pain and discomfort during scaling and root planning by a bupivacaine lozenge in comparison to lidocaine-adrenalin injections.</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain and discomfort are measured immediately after the scaling and root planning procedure
Level of pain:
-Visual Analog Scale (VAS) 0-10 where 0 = no pain, 10 = extreme pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To demonstrate a non-inferior effect on pain and discomfort during scaling and root planning by a bupivacaine lozenge in comparison to lidocaine-adrenalin injections.</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain and discomfort are measured immediately after the scaling and root planning procedure
Level of discomfort:
-Visual Analog Scale (VAS) 0-10 where 0 = no discomfort, 10 = extreme discomfort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator evaluation of the scaling procedure</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>After the scaling and root planning the investigator evaluates the scaling procedure by a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of the two pharmaceutical formulations</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>After the scaling procedure the patient assesses the two pharmaceutical formulations by a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To demonstrate a non-inferior effect on pain and discomfort during scaling and root planning by a bupivacaine lozenge in comparison to lidocaine-adrenalin injections.</measure>
    <time_frame>Daiy 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain and discomfort are measured immediately after the scaling and root planning procedure
Level of pain:
-McGills Pain Questionnaire (MPQ), which gives a qualitative pain profile</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain and Discomfort During Scaling and Root Planning of Patients With</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Bupivacaine lozenge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine-adrenalin injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine lozenge</intervention_name>
    <arm_group_label>Bupivacaine lozenge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine-adrenalin injection</intervention_name>
    <arm_group_label>Lidocaine-adrenalin injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed as having, respectively periodontitis marginalis adulta
             progressiva lenta and periodontitis marginalis adulta progressiva rapid in the
             hygiene phase, where depurations are repeated within a short timeframe

          -  Age between 18 and 80 years

          -  Ability to speak, read and understand danish

          -  Ability to give oral and written consent

        Exclusion Criteria:

          -  Known allergy to bupivacaine or other local anaesthetics of the amide type

          -  Other gingival infections (eg lichen planus)

          -  Pregnancy -if in doubt a pregnancy test will be made

          -  Breastfeeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ove Andersen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hvidovre UH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlotte Treldal, M.Sc.Pharm</last_name>
    <phone>+45 38626077</phone>
    <email>sugetablet@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stine Mogensen, M.Sc.Pharm</last_name>
    <phone>+45 38626077</phone>
    <email>sugetablet@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tandlægerne Vimmelskaftet</name>
      <address>
        <city>Copenhagen K</city>
        <zip>1161</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Søren Barsted, Dentist</last_name>
      <phone>+45 33 93 03 38</phone>
      <email>sbar@sund.ku.dk</email>
    </contact>
    <investigator>
      <last_name>Søren Barsted, Dentist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Frederiksberg Tandlægerne</name>
      <address>
        <city>Frederiksberg</city>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Strandgaard, MD</last_name>
      <phone>+45 35398585</phone>
      <email>fredtand@fredtand.dk</email>
    </contact>
    <investigator>
      <last_name>Maria Strandgaard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lihn Vy Truc, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sune Holm, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mette Jensen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tandlægepraksis ved Jonna Bork</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marlene Holm, Dental technician</last_name>
      <phone>+45 36780433</phone>
      <email>jonnabork@mail.tele.dk</email>
    </contact>
    <investigator>
      <last_name>Jonna Bork, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>June 13, 2013</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Ove Andersen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
